KLRS
Kalaris Therapeutics
KLRS
KLRS
84 hedge funds and large institutions have $502M invested in Kalaris Therapeutics in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.02% less ownership
Funds ownership: 1.78% → 1.77% (-0.02%)
16% less capital invested
Capital invested by funds: $600M → $502M (-$98.1M)
Holders
84
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$8.28M | |
| 2 | +$6.04M | |
| 3 | +$4.86M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.63M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.29M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$10.1M | |
| 3 | -$7.1M | |
| 4 |
Goldman Sachs
New York
|
-$3.98M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.58M |